2. Academic Validation
  3. CRELD2, endoplasmic reticulum stress, and human diseases

CRELD2, endoplasmic reticulum stress, and human diseases

  • Front Endocrinol (Lausanne). 2023 Mar 2:14:1117414. doi: 10.3389/fendo.2023.1117414.
Qin Tang 1,  Qinhui Liu 1,  Yanping Li 1,  Li Mo 2,  Jinhan He 1
Affiliations

Affiliations

  • 1 Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • 2 Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
PMID: 36936176 DOI: 10.3389/fendo.2023.1117414
Abstract

CRELD2, a member of the cysteine-rich epidermal growth factor-like domain (CRELD) protein family, is both an endoplasmic reticulum (ER)-resident protein and a secretory factor. The expression and secretion of CRELD2 are dramatically induced by ER stress. CRELD2 is ubiquitously expressed in multiple tissues at different levels, suggesting its crucial and diverse roles in different tissues. Recent studies suggest that CRELD2 is associated with cartilage/bone metabolism homeostasis and pathological conditions involving ER stress such as chronic liver diseases, cardiovascular diseases, kidney diseases, and Cancer. Herein, we first summarize ER stress and then critically review recent advances in the knowledge of the characteristics and functions of CRELD2 in various human diseases. Furthermore, we highlight challenges and present future directions to elucidate the roles of CRELD2 in human health and disease.

Keywords

CRELD2; endoplasmic reticulum stress; human diseases; metabolism; unfolded protein response.

Figures
Products